Skip to main content
. 2020 Sep 21;64(10):e00398-20. doi: 10.1128/AAC.00398-20

TABLE 2.

Impact of KPC-2 W105 mutations on nitrocefin and meropenem hydrolysis

Enzyme mutation Nitrocefin
Meropenem
Km (μM) kcat (s−1) kcat/Km (s−1 μM−1) Km (μM) kcat (s−1) kcat/Km (s−1 μM−1)
WT 43 ± 4 190 ± 6 4.40 ± 0.25 15 ± 2 3.8 ± 0.1 0.26 ± 0.02
W105F 71 ± 3 192 ± 13 2.70 ± 0.07 16 ± 2 1.8 ± 0.1 0.12 ± 0.01
W105N 160 ± 14 135 ± 17 0.84 ± 0.04 59 ± 5 3.1 ± 0.1 0.053 ± 0.003
W105L 357 ± 18 290 ± 4 0.81 ± 0.03 55 ± 4 2.5 ± 0.1 0.046 ± 0.002
W105V 236 ± 9 198 ± 8 0.84 ± 0.06 59 ± 7 4.2 ± 0.3 0.073 ± 0.007
W105D 558 ± 68 172 ± 10 0.31 ± 0.02 122 ± 4 15.7 ± 0.2 0.129 ± 0.003
W105A 299 ± 29 238 ± 3 0.80 ± 0.07 65 ± 10 2.8 ± 0.2 0.044 ± 0.004
W105Y 79 ± 5 247 ± 9 3.12 ± 0.11 19 ± 1 2.6 ± 0.04 0.14 ± 0.01
W105S 293 ± 11 169 ± 3 0.58 ± 0.02 64 ± 8 2.2 ± 0.2 0.035 ± 0.001